In an interview with K-Mag, Olivia Falconnier Williams talks about her research findings on more sustainable blister packaging and her experiences as a young scientist - and gives tips to other young researchers.
What prompted your research on the topic of waste prevention in blister packaging?
Olivia Falconnier Williams: Now that the healthcare system has become one of the largest consumers of resources in Western countries, responsible management of these resources is becoming increasingly important. Awareness of this connection is only just emerging in the healthcare sector and general standards for sensible resource conservation have neither been discussed nor introduced. This makes it all the more important to identify options that conserve resources and can be implemented immediately without any loss of quality or regulatory obstacles.
What conclusions have you drawn from your research?
Falconnier Williams: In a very large sample of medicines that are very frequently taken in Germany, we showed that they are predominantly packaged in individual blisters, but practically never in a resource-saving manner. For example, the packaging material of the blister strips between the blister chambers typically took up much more space (= material requirement) than the actual blister chambers. The extrapolation of an optimal placement with little space in between showed that typically one third of the packaging material - plastic-aluminum composite material, rarely mainly aluminum - could be saved.
For many reasons, this practice should be changed as soon as possible:
- it is not necessary to leave such large gaps for the correct removal of medicines.
- The material used is practically never recycled, as it is difficult to separate the glued or welded (composite) materials again in a meaningful and economical way.
- The secondary packaging that wraps the blister strips is also correspondingly larger, which is why the avoidable weight of the primary packaging is automatically added to the avoidable weight of the secondary packaging; both lead to larger transport volumes and weights and ultimately to higher transport costs per dosage form.
Given the sheer volume of medicines consumed in Germany (and worldwide) and the extremely long transport routes (due to production often on other continents), it is astonishing why this has not been optimized long ago.